Highlights Pharmagreen Biotech Inc. OTC Markets

Equities

PHBI

US00922N1046

Delayed OTC Markets Other stock markets 08:41:07 05/10/2021 pm IST			5-day change	1st Jan Change
0.0289 ^USD	-.--%		-4.87%	+172.64%

21/02	Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI
09/01	Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	21/02	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	09/01	CI
Pharmagreen Starts Sales of MaxGenomicTM Supplement on Amazon.Com and Develops Its Next Pre-Workout Formulation	05/23/05	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	15/23/15	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	20/23/20	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	15/23/15	CI
Pharmagreen Biotech, Inc. Launches Online Sales for Its MaxGenomic(TM) Supplement Product	08/23/08	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	17/23/17	CI
Pharmagreen Biotech Inc. Develops a Proprietary Nutraceutical Formulation and Prepares for Product Launch	08/22/08	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	18/22/18	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	16/22/16	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021	23/22/23	CI
Pharmagreen Biotech Inc. completed the acquisition of Long Valley Farms LLC.	20/22/20	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2021	30/21/30	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2021	19/21/19	CI
Pharmagreen Biotech Inc. entered into memorandum of understanding to acquire Long Valley Farms LLC for $2.4 million.	12/21/12	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2021	25/21/25	CI
Pharmagreen Biotech Inc. Signs LOI to Supply Crude CBD Oil Extracted from Certified Organically Grown Hemp Biomass	16/21/16	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2020	09/21/09	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2020	20/20/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pharmagreen Biotech Inc. OTC Markets

Equities

PHBI

US00922N1046

Highlights

Filters